6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: Reflections and recommendations
Journal article   Open access   Peer reviewed

Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: Reflections and recommendations

Nagham J Ailabouni, Kristie Rebecca Weir, Nicole Brandt, Leila Shafiee Hanjani, Ariel Green, Wade Thompson, Christopher R Freeman, Dee Mangin, Ruth Bohill, Chloe Furst, …
Basic & clinical pharmacology & toxicology, Vol.134(1), pp.121-125
01/2024
Handle:
https://hdl.handle.net/10523/23699

Abstract

Dementia - drug therapy co-design consumer engagement dementia deprescribing health information
Empowering people living with dementia to be active partners in conversations about their medicines is imperative. Consumers, people living with dementia and their carers, have reported limited confidence to start conversations with their healthcare professional (HCP) about deprescribing, reducing or stopping, their medicines.
pdf
Basic Clin Pharma Tox - 2023 - Ailabouni - Partnering with a stakeholder steering group to co‐design the PRIME134.96 kBDownloadView
Published (Version of record)CC BY V4.0 Open Access
url
https://doi.org/10.1111/bcpt.13938View
Published (Version of record)CC BY V4.0 Open

Metrics

29 File views/ downloads
17 Record Views

Details

Logo image